These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 35899960

  • 1. Galbanic Acid Improves Accumulation and Toxicity of Arsenic Trioxide in MT-2 Cells.
    Mahdifar M, Rassouli FB, Iranshahi M, Goudarzi S, Golizadeh M, Rafatpanah H.
    Anticancer Agents Med Chem; 2023; 23(6):699-708. PubMed ID: 35899960
    [Abstract] [Full Text] [Related]

  • 2. Arsenic trioxide induces accumulation of cytotoxic levels of ceramide in acute promyelocytic leukemia and adult T-cell leukemia/lymphoma cells through de novo ceramide synthesis and inhibition of glucosylceramide synthase activity.
    Dbaibo GS, Kfoury Y, Darwiche N, Panjarian S, Kozhaya L, Nasr R, Abdallah M, Hermine O, El-Sabban M, de Thé H, Bazarbachi A.
    Haematologica; 2007 Jun; 92(6):753-62. PubMed ID: 17550847
    [Abstract] [Full Text] [Related]

  • 3. Ethacrynic acid and a derivative enhance apoptosis in arsenic trioxide-treated myeloid leukemia and lymphoma cells: the role of glutathione S-transferase p1-1.
    Wang R, Liu C, Xia L, Zhao G, Gabrilove J, Waxman S, Jing Y.
    Clin Cancer Res; 2012 Dec 15; 18(24):6690-701. PubMed ID: 23082001
    [Abstract] [Full Text] [Related]

  • 4. Increased growth-inhibitory and cytotoxic activity of arsenic trioxide in head and neck carcinoma cells with functional p53 deficiency and resistance to EGFR blockade.
    Boyko-Fabian M, Niehr F, Distel L, Budach V, Tinhofer I.
    PLoS One; 2014 Dec 15; 9(6):e98867. PubMed ID: 24927258
    [Abstract] [Full Text] [Related]

  • 5. Arsenic trioxide-induced apoptosis in myeloma cells: p53-dependent G1 or G2/M cell cycle arrest, activation of caspase-8 or caspase-9, and synergy with APO2/TRAIL.
    Liu Q, Hilsenbeck S, Gazitt Y.
    Blood; 2003 May 15; 101(10):4078-87. PubMed ID: 12531793
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Arsenic trioxide induces apoptosis and G2/M phase arrest by inducing Cbl to inhibit PI3K/Akt signaling and thereby regulate p53 activation.
    Li Y, Qu X, Qu J, Zhang Y, Liu J, Teng Y, Hu X, Hou K, Liu Y.
    Cancer Lett; 2009 Nov 01; 284(2):208-15. PubMed ID: 19457607
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Synergistic lethal effect of combined treatment of arsenic trioxide and aclacinomycin on human acute myeloid leukemia cell line KG-1a].
    Ye YB, Xu XJ, Chen YH, Zhang MW, Qiu DF, Guo ZW, He HQ.
    Zhonghua Zhong Liu Za Zhi; 2017 Apr 23; 39(4):256-262. PubMed ID: 28550664
    [Abstract] [Full Text] [Related]

  • 12. miRNA-21 regulates arsenic-induced anti-leukemia activity in myelogenous cell lines.
    Gu J, Zhu X, Li Y, Dong D, Yao J, Lin C, Huang K, Hu H, Fei J.
    Med Oncol; 2011 Mar 23; 28(1):211-8. PubMed ID: 20143188
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Combinatorial Effect of Arsenic and Herbal Compounds in Telomerase-Mediated Apoptosis Induction in Liver Cancer.
    Chaudhary A, Bhardwaj SK, Khan A, Srivastava A, Sinha KK, Ali M, Haque R.
    Biol Trace Elem Res; 2023 Jul 23; 201(7):3300-3310. PubMed ID: 36192614
    [Abstract] [Full Text] [Related]

  • 16. Synergy between parthenolide and arsenic trioxide in adult T-cell leukemia/lymphoma cells in vitro.
    Kouhpaikar H, Sadeghian MH, Rafatpanah H, Kazemi M, Iranshahi M, Delbari Z, Khodadadi F, Ayatollahi H, Rassouli FB.
    Iran J Basic Med Sci; 2020 May 23; 23(5):616-622. PubMed ID: 32742599
    [Abstract] [Full Text] [Related]

  • 17. Conferone, a coumarin from Ferula flabelliloba, induced toxic effects on adult T-cell leukemia/lymphoma cells.
    Rafatpanah H, Golizadeh M, Mahdifar M, Mahdavi S, Iranshahi M, Rassouli FB.
    Int J Immunopathol Pharmacol; 2023 May 23; 37():3946320231197592. PubMed ID: 37688389
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Differential effects of arsenic trioxide on chemosensitization in human hepatic tumor and stellate cell lines.
    Rangwala F, Williams KP, Smith GR, Thomas Z, Allensworth JL, Lyerly HK, Diehl AM, Morse MA, Devi GR.
    BMC Cancer; 2012 Sep 10; 12():402. PubMed ID: 22963400
    [Abstract] [Full Text] [Related]

  • 20. Combination effects of arsenic trioxide and fibroblast growth factor receptor inhibitor in squamous cell lung carcinoma.
    Lam SK, Leung LL, Li YY, Zheng CY, Ho JC.
    Lung Cancer; 2016 Nov 10; 101():111-119. PubMed ID: 27794399
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.